BCAB
USDBioAtla Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$0.650
Máximo
$0.678
Mínimo
$0.613
Volumen
0.11M
Fundamentos de la Empresa
Capitalización de Mercado
39.5M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
1.01M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its
Acciones Relacionadas
VLYPP
Valley National Bancorp 6.25% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series A
CHPT
ChargePoint Holdings Inc.
FMAO
Farmers & Merchants Bancorp Inc.
CHRO
Chromocell Therapeutics Corporation
VOYA
Voya Financial Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.